Seroquel is So Profitable, AstraZeneca is Glad to Pay Millions in Penalties

Sunday, March 20, 2011
Paying nearly $600 million as a result of lawsuits really isn’t that bad when the product that supposedly got you into trouble earns billions of dollars each year.
 
That’s the reality for pharmaceutical manufacturer AstraZeneca, maker of the anti-psychotic drug Seroquel (quetiapine fumarate). On March 10, AstraZeneca agreed to pay $68.5 million as part of the largest multi-state consumer protection settlement on record for unlawful marketing of Seroquel. This is in addition to last year’s $520 million to settle accusations of burying side effect and safety information related to the drug.
 
But these settlements are easily absorbed by a company that made $5.3 billion just last year selling Seroquel, a drug that was approved for treatment of schizophrenia, bipolar disorder, psychiatric conditions in children and as an add-on for patients taking anti-depressants. However, AstraZeneca has made its real profits on the drug by marketing it for use against symptoms and maladies for which it had never been approved, such as Alzheimer's, autism, obsessive dementia, anger management, anxiety, attention-deficit hyperactivity disorder and post-traumatic stress disorder.
-David Wallechinsky
 
AstraZeneca to Pay $68.5 Million to U.S. States Over Seroquel Marketing (by Margaret Cronin Fisk and Jef Feeley, Bloomberg)
Doctors Alarmed by Military’s Use of Mind Drugs on Troops (by Noel Brinkerhoff and David Wallechinsky, AllGov)
Drug Giant AstraZeneca to Pay $520 Million to Settle Fraud Case (by Huma Khan and Pierre Thomas, ABC News)

Comments

Daniel Haszard 8 years ago
Zyprexa,Risperdal and Seroquel same saga The use of powerful antipsychotic drugs has increased in children as young as three years old. Weight gain, increases in triglyceride levels and associated risks for diabetes and cardiovascular disease. The average weight gain (adults) over the 12 week study period was the highest for Zyprexa—17 pounds. You’d be hard pressed to gain that kind of weight sport-eating your way through the holidays. One in 145 adults died in clinical trials of those taking the antipsychotic drugs Zyprexa. This is Lilly's # 1 product over $ 4 billion year sales,moreover Lilly also make billions on drugs that treat the diabetes often that has been caused by the zyprexa! --- Daniel Haszard Zyprexa victim activist and patient who got diabetes from it. http://www.zyprexa-victims.com
James Pricer 8 years ago
Thank you for giving perspective to these 'fines'. I have linked to your article on my website because it is a good example of how the government and big pharma collude to continue the money stream into pockets of senior management and government officials. Anything short of jail is not going to make a difference. James Pricer ThePsychReport.com

Leave a comment